Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Pituitary|July 3, 2008
What are critical outcome measures for patients receiving pituitary replacement following brain injury?Sorin G Beca, Walter M High, Brent E Masel, et al.Journal of Translational Science|October 12, 2020
Pharmacological approaches to the treatment of COVID-19 patientsLawrence C Sowers, Lucas S Blanton, Scott C Weaver, et al.The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Differential anabolic effects of testosterone and amino acid feeding in older menArny A Ferrando, Melinda Sheffield-Moore, Douglas Paddon-Jones, et al.Annals of Epidemiology|August 18, 2020
Testosterone prescribing in men with depression and anxiety disordersZulqarnain Javed, Yong-Fang Kuo, Jeff R Temple, et al.Mayo Clinic Proceedings|August 6, 2020
Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)Rasha A Al-Lami, Randall J Urban, Elena Volpi, et al.Mayo Clinic Proceedings|July 25, 2015
Risk of Venous Thromboembolism in Men Receiving Testosterone TherapyJacques Baillargeon, Randall J Urban, Abraham Morgentaler, et al.The Journal of Clinical Endocrinology and Metabolism|December 16, 2004
The catabolic effects of prolonged inactivity and acute hypercortisolemia are offset by dietary supplementationDouglas Paddon-Jones, Melinda Sheffield-Moore, Randall J Urban, et al.The Journal of Clinical Endocrinology and Metabolism|November 12, 2014
Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult malesRobert H Fitts, James R Peters, E Lichar Dillon, et al.Recent Progress in Hormone Research|June 11, 2003
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedsideJohn A Copland, Peter J Davies, Gregory L Shipley, et al.Andrology|April 29, 2022
Association of testosterone therapy with disease progression in older males with COVID-19Jacques Baillargeon, Yong-Fang Kuo, Jordan Westra, et al.Pageof 8